Werfen Achieves Key Milestone with FDA and CE Approval for Aptiva Antiphospholipid Syndrome IgA Reagent #USA #San_Diego #Werfen #Aptiva #Antiphospholipid_Syndrome
@newsen.bsky.social@newsen.bsky.social
@newsen.bsky.socialWerfen Achieves Key Milestone with FDA and CE Approval for Aptiva Antiphospholipid Syndrome IgA Reagent #USA #San_Diego #Werfen #Aptiva #Antiphospholipid_Syndrome